Company intelligence / Profile preview

Synergy Clinical Research

National City, California, United Statessynergyresearchcenters.com ↗

Ownership: Private
Development stage: Commercial

Overview

Synergy Clinical Research operates as a clinical research center and consulting organization, conducting industry-sponsored trials in indications such as migraine and schizophrenia. The company has contributed to studies evaluating the efficacy of rimegepant in patients with migraines already receiving CGRP monoclonal antibodies, as well as advancing long-term injectable therapies for schizophrenia. Their work supports both investigational new drugs and post-marketing studies, focusing on patient recruitment, protocol execution, data quality review, medical monitoring, and inspection readiness[5][6].

Therapeutic areas: PsychiatryNeurology
Modalities: Small moleculeMonoclonal antibody
Industry: Contract Research Organization

Beyond the preview

Go deeper on Synergy Clinical Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synergy Clinical Research.

Explore the full profile